Authors: PARISE P ASCANI A MORINI M BIGARONI A ZANUTTINI F NENCI GG

Citation: P. Parise et al., FIXED-DOSE OF LMWH REVIPARIN IS MORE EFFECTIVE THAN ADJUSTED-DOSE OF UH IN INHIBITING THROMBIN GENERATION IN PATIENTS AT RISK OF THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 1165-1165

Authors: BERRETTINI M ASCANI A PARISE P MORINI M MALASPINA M ZANUTTINI F NENCI GG

Citation: M. Berrettini et al., THE RELEASE OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) IN PATIENTS RECEIVING PROPHYLACTIC ANTITHROMBOTIC REGIMENS WITH UNFRACTIONED HEPARIN OR LMWH (REVIPARIN), Thrombosis and haemostasis, 1997, pp. 1674-1674